Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

By sjmartinez • November 11, 2023

Jensen TO, Grandits GA, Jain MK, Murray TA, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens RA, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER; ACTIV-3/TICO Study Group. Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19. J Infect Dis. 2023 Nov 9:jiad446. doi: 10.1093/infdis/jiad446. Epub ahead of print. PMID: 37948759.

Tags: anti-nucleocapsid antibody, Cedars Sinai DoM, covid-19, Harbor UCLA, Infectious Diseases, inflammatory biomarkers, neutralizing monoclonal antibody, plasma nucleocapsid antigen, Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and altered bile pathway gene expression

Zhao X, Zhou J, Chyu KY, Erbay E, Cercek B, Shah PK, Dimayuga PC. Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and[...]

Lifestyle and Behavioral Enhancements of Sleep: A Review

Jiyeon S, Oragun R, Dennis S, Elen G, Fariha H, Sherzai D, Roy A. Lifestyle and Behavioral Enhancements of Sleep: A Review. Am J Lifestyle[...]

cGAS-STING dependent type I IFN reduces Leptospira interrogans renal colonization in mice

Gupta S, Matsunaga J, Ratitong B, Manion A, Ismaeel S, Valadares DG, West AP, Kerur N, Stehlik C, Dorfleutner A, Dagvadorj J, Coburn J, Wolf[...]